Rigel Pharmaceuticals Inc 10-Q for FY2026 Q2
Rigel Pharmaceuticals Inc (RIGL)
10-Q
2026-08-04
For: 2026-06-30
View Original
Added on
August 04, 2026
About this 10-Q
Rigel Pharmaceuticals Inc filed this 10-Q on August 4, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).
Headline figures
Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $78.7M
- down 22.6% from $101.69M a year earlier
- Net income
- $17.29M
- down 71.0% from net income of $59.61M a year earlier
- Diluted EPS
- $0.88
- down 73.2% from $3.28 a year earlier